赛托生物：暂无直接生产适用于COPD的制剂

Group 1 - The company, Saito Bio (300583), produces key starting materials for common COPD treatments, including dehydroepiandrosterone, betamethasone, and indacaterol maleate [1] - The company does not currently produce formulations specifically for COPD [1]